Inflammatory problems: For gastrointestinal problems, analysis has shown that cannabinoids “happen to be shown to control the tissue response to abnormal inflammation within the colon.” The scientists reported that this means that cannabinoid modulation from the ECS “could be a promising therapeutic tool with the therapy of several conditions